Heterogeneity in Characteristics and Outcomes of Patients who met the Indications for Vericiguat Approved by the Japanese Agency: From the KCHF Registry

Affiliations

• ¹ Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
• ² Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: tkato75@kuhp.kyoto-u.ac.jp.
• ³ Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
• ⁴ Department of Cardiology, Mitsubishi Kyoto Hospital, Kyoto, Japan.
• ⁵ Cardiovascular Medicine, Shiga General Hospital, Moriyama, Japan.
• ⁶ Division of Cardiology, Tenri Hospital, Tenri, Japan.
• ⁷ Division of Heart Failure, National Cerebral and Cardiovascular Center, Suita, Japan.
• ⁸ Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
• ⁹ Department of Cardiology, Osaka Red Cross Hospital, Osaka, Japan.
• ¹⁰ Department of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.
• ¹¹ Department of Cardiology, Kokura Memorial Hospital, Kokura, Japan.
• ¹² Department of Cardiology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
• ¹³ Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
• ¹⁴ Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
• ¹⁵ Department of Cardiovascular Medicine, Shinshu University Graduate School of Medicine, Nagano, Japan.